R. A. Stockley (Birmingham, United Kingdom), A. Dirksen (Copenhagen, Denmark)
GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency
C. O. de la Roza, R. Vidal, F. Rodriguez-Frias, X. Costa, S. Vila, B. Lara, R. Jardi, M. Miravitlles (Barcelona, Spain)
|  |
The role of genetic polymorphisms of glutation-S-transferase μ1 (GSTM1) and gelatinase B (MMP9) in the risk of COPD development
E. D. Iantchina, T. V. Ivtchik, N. E. Khodzhayants, E. I. Schwartz, L. N. Karlova, A. N. Kokosov (St Petersburg, Russia)
|  |
Sibling pairs with alpha-1-antitrypsin deficiency
M. Needham, D. A. Parr, S. L. Hill, R. A. Stockley (Birmingham, United Kingdom)
| |
Diagnosis of pulmonary emphysema by quantitative computed tomography (CT), aerosol morphometry and aerosol bolus dispersion
S. Shaker, N. Maltbaek, P. Brand, S. Haeussermann, A. Dirksen (Hellerup, Denmark; Neuherberg, Dresden, Germany)
| |
Correlation between annual change in health status and CT-derived lung density in subjects with alpha-1-antitrypsin deficiency
J. Stolk, W. H. Ng, E. M. Bakker, J. H. C. Reiber, K. F. Rabe, B. C. Stoel (Leiden, The Netherlands)
| |
Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency
V. Romberg, K. Roskos, J. Stocks, M. Phillips, M. Brantly (King of Prussia, San Carlos, Tyler, Gainseville)
| |
Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years
M. Needham, D. M. Griffiths, H. M. Wilkins, R. A. Stockley (Birmingham, United Kingdom)
| |
Physiological measures in the assessment of emphysema in patients diagnosed with COPD in primary care
A. J. White, J. Shakespeare, P. J. Guest, S. L. Hill, R. A. Stockley (Birmingham, United Kingdom)
| |